ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma

Table 1

Logistic regression of ARID1A expression and clinical pathological characteristics.

Clinical characteristics	Total	Odds rate in ARDI2 expression	p value
Age (<55 versus ≥55)	366	1.13(0.75–1.83)	0.412
Gender (male versus female)	377	0.35(0.24–0.57)	<0.001
Grade (G2 versus G1)	235	1.24(0.73–2.50)	0.331
Grade (G3 versus G1)	179	1.62(0.81–3.27)	0.109
Grade (G4 versus G1)	68	1.59(0.46–1.93)	0.625
Stage (2v1)	262	1.11(0.62–1.61)	0.875
Stage (3v1)	261	1.26(1.03–2.72)	0.053
Stage(4v1)	200	1.79(0.45–6.92)	0.432
T (T2 versus T1)	280	1.18(0.79–2.23)	0.351
T (T3 versus T1)	266	1.92(1.03–3.22)	0.014
T (T4 versus T1)	198	0.81(0.23–2.35)	0.639
M (M1 versus M0)	276	1.35(0.29–6.83)	0.731
N (N1 versus N0)	261	3.16(0.78–20.23)	0.178